1. Barkagan Z.S., Momot A.P. Basic methods of laboratory diagnosis of hemostatic disorders. Barnaul, 1998. 10–11. (in Russian)
2. Byshevskiy A.Sh., Galyan S.L., Ral,chenko I.V. et. al. Effect of combination of antioxidant vitamins on hemostasis in experimental hyperoxidation // Tromboz, gemostaz, reologiya. 2005. 68. (3). 34–36. (in Russian)
3. Galagan M.E., Shirokolova A.V., Vanin A.F. Hypotensive effect of nitrogen oxide, produced from exogenous and endogenous sources // Voprosy meditsinskoy khimii. 1991. 37. (1). 67–70. (in Russian)
4. Dobrokhotova Yu. E. Menopausal syndrome. M.: RGMU, 2005. 2–24. (in Russian)
5. Kirshenblat Ya.D. Workshop on Endocrinology. Мoscow, 1969. 55–57. (in Russian)
6. Plotnikov M.B., Aliev O.I., Plotnikova T.M. Methodological approaches to studying substances influencing blood rheology // Eksperimental'naya i klinicheskaya farmakologiya. 2011. 74. (12). 36–40. (in Russian)
7. Plotnikova T.M., Shul,gau Z.T., Plotnikova A.M. et. al. Effects of Maackia amurensis extract on the lipid spectrum and lipid peroxidation in erythrocyte membranes of ovariectomized rats // Eksperimental'naya i klinicheskaya farmakologiya. 2008. 71. (6). 28–30. (in Russian)
8. Khabriev R.U. Guidelines for experimental (preclinical) studies of new pharmacological agents. М., 2005. 832 p. (in Russian)
9. Smetnik V.P. Menopausal disorders and methods for their correction // Consilium medicum. 2007. 9. (6). 65–70. (in Russian)
10. Pignon B., Jolly D., Patron G. Erythrocyte aggregation-determination of normal values. Influence of age, sex, hormonal state, oestroprogestative treatment, haematological parameters and cigarette smoking // Nouv. Rev. Fr. Hematol. 1994. 36. (6). 431–439.
11. Stoltz J.E., Donner M. New trends in clinical hemorheology: an introduction to the concept of the hemorheological profile // Schweiz. Med. Wochenschr. 1991. 43. 41–49.
12. Vaya A., Chorro P., Julia D. et al. Menopause, hormone replacement therapy and hemorheology // Clin. Hemorheol. Microcirc. 2004. 30. 277–281.
13. Writing Group for the Women’s Health Initiative Investigators. Risk and benefit of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomizes controlled trail // JAMA. 2002. 288. 321–333.
About Authors (Correspondence):
Anishchenko A.M. – candidate of medical sciences, researcher of laboratory of circulation pharmacology
Aliev O.I. – doctor of medical sciences, leading researcher of laboratory of circulation pharmacology
Plotnikova T.M. – doctor of biological sciences, professor of the chair for pharmacology, e-mail: mbp2001@mail.ru